INTEGRATED PRECLINICAL/CLINICAL AIDS VACCINE DEVELOPMENT 

NIH GUIDE, Volume 26, Number 18, May 30, 1997

 

PA NUMBER:  PAR-97-056

 

P.T. 34



Keywords:

  AIDS 

  Vaccine 

 

National Institute of Allergy and infectious Diseases

 

This notice is an addendum to Program Announcement (PA) PAR-97-056,

Integrated Preclinical/Clinical AIDS Vaccine Development, which was

published in the NIH Guide for Grants and Contracts, Vol. 26, No. 13,

April 25, 1997.  The purpose  of this notice is to inform potential

applicants of the following modification under MECHANISM OF SUPPORT

concerning the first year total costs:  P01 grant applications

submitted in response to this PA should not request more than $1

million first-year total (direct plus indirect) costs.  This limit

may be exceeded, but applicants will need to provide a comprehensive

and detailed justification for doing so.  This justification should

be included as part of the application and will be reviewed by the

Scientific Peer Review Group.

 

INQUIRIES

 

Direct inquiries regarding this addendum to:

 

Dr. Steven Bende

Division of AIDS

National Institute of Allergy and Infectious Diseases

6003 Executive Boulevard, Room 2A29

Bethesda, MD  20892-7620

Telephone:  (301) 435-3756

FAX:  (301) 402-3684

Email:  [email protected]

 

.

Return to 1997 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)